Through his work on the podcast “Futures in Biotech,” scientist Marc Pelletier has access to some of the field’s top minds. He’s using that access to shape his own thinking as early stage startup, Aeromics, looks to develop a drug to reduce swelling in the brain.

The company will use the grant to further its development of a drug that reduces brain swelling in stroke victims.